                         SEQUENCE LISTING

<110>  ONTOCHEM GmbH
 
<120>  Receptor-targeting Peptide-Drug Conjugates

<130>  23395-PCT

<150>  EP 19188092
<151>  2019-07-24

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Analogue of Neuropeptide Y


<220>
<221>  MISC_FEATURE
<222>  (33)..(33)
<223>  Arg or a group of formula -N(R2)-CH(R3)-(CH2)n-C(=O)-, wherein R2
       is hydrogen or a methyl group, R3 is hydrogen or a linear or 
       branched C1-8 alkyl group and n is 0 or 1; with the proviso that 
       Arg is excluded when Xaa35 is Arg and Xaa36 is Tyr

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  Arg or a group of formula -N(R4)-CH(R5)-(CH2)m-C(=O)-, wherein R4
       is hydrogen or a methyl group, R5 is hydrogen or a linear or 
       branched C1-8 alkyl group and m is 0 or 1

<220>
<221>  MISC_FEATURE
<222>  (36)..(36)
<223>  Tyr or a group of formula -N(R6)-CH(R7)-(CH2)p-C(=O)-, wherein R6
       is hydrogen or a methyl group, R7 is hydrogen or a linear or 
       branched C1-8 alkyl group and p is 0 or 1

<400>  1

Tyr Pro Ser Lys Pro Asp Phe Pro Gly Glu Asp Ala Pro Ala Glu Asp 
1               5                   10                  15      


Leu Ala Arg Tyr Tyr Ser Ala Leu Arg His Tyr Ile Asn Leu Ile Thr 
            20                  25                  30          


Xaa Pro Xaa Xaa 
        35      


<210>  2
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Analogue of Neuropeptide Y


<220>
<221>  MISC_FEATURE
<222>  (33)..(33)
<223>  alanine, valine, leucine, isoleucine, beta-alanine, 
       N-methyl-alanine, norvaline, norleucine, beta-homo-leucine, 
       beta-homo-isoleucine, N-methyl-isoleucine, N-methyl-norleucine

<220>
<221>  MISC_FEATURE
<222>  (35)..(35)
<223>  alanine, valine, leucine, isoleucine, beta-alanine, 
       N-methyl-alanine, norvaline, norleucine, beta-homo-leucine, 
       beta-homo-isoleucine, N-methyl-isoleucine, N-methyl-norleucine

<220>
<221>  MISC_FEATURE
<222>  (36)..(36)
<223>  alanine, valine, leucine, isoleucine, beta-alanine, 
       N-methyl-alanine, norvaline, norleucine, beta-homo-leucine, 
       beta-homo-isoleucine, N-methyl-isoleucine, N-methyl-norleucine

<400>  2

Tyr Pro Ser Lys Pro Asp Phe Pro Gly Glu Asp Ala Pro Ala Glu Asp 
1               5                   10                  15      


Leu Ala Arg Tyr Tyr Ser Ala Leu Arg His Tyr Ile Asn Leu Ile Thr 
            20                  25                  30          


Xaa Pro Xaa Xaa 
        35      


<210>  3
<211>  36
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Analogue of Neuropeptide Y

<400>  3

Tyr Pro Ser Lys Pro Asp Phe Pro Gly Glu Asp Ala Pro Ala Glu Asp 
1               5                   10                  15      


Leu Ala Arg Tyr Tyr Ser Ala Leu Arg His Tyr Ile Asn Leu Ile Thr 
            20                  25                  30          


Ala Pro Ala Ala 
        35      


